Cardiac Hypertrophy: A Risk Factor for QT-Prolongation and Cardiac Sudden Death

By Kang Y.  

Toxicologic Pathology, Vol. 34, Iss. 1, 2006-03 ,pp. : 58-66

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Potential surrogate markers of cerebral microvascular angiopathy in asymptomatic subjects at risk of stroke

By Selvarajah Johann  

European Radiology, Vol. 19, Iss. 4, 2009-04 ,pp. : 1011-1018

Springer Publishing Company

Access to resources Recommend Favorite

Establishing the clinical utility of epigenetic markers in cancer: many challenges ahead

By Zarzour Peter   Hesson Luke B   Ward Robyn L  

Epigenomics, Vol. 5, Iss. 5, 2013-10 ,pp. : 513-523

Future Medicine

Access to resources Recommend Favorite

FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity

By Saboury Babak   Salavati Ali   Brothers Alex   Basu Sandip   Kwee Thomas   Lam Marnix   Hustinx Roland   Louis Edouard   Torigian Drew   Alavi Abass  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, Iss. 4, 2014-04 ,pp. : 605-614

Springer Publishing Company

Access to resources Recommend Favorite

CLINICAL UTILITY OF ANTICARDIOLIPIN ANTIBODY ASSAYS: HIGH INTER-LABORATORY VARIATION AND LIMITED CONSENSUS BY PARTICIPANTS OF EXTERNAL QUALITY ASSURANCE PROGRAMS SIGNALS A CAUTIOUS APPROACH

By Favaloro Emmanuel J.   Silvestrini Roger   Mohammed Ali  

Pathology, Vol. 31, Iss. 2, 1999-05 ,pp. : 142-147

Ashgate Publishing Ltd

Access to resources Recommend Favorite